Fosphenytoin Sodium Injection Articles
Industry bodies oppose annual revision of Japan
7 August 2006
Tokyo pharma stocks - week to July 29
5 August 2002
Brand name confusion "a risk for patients"
27 May 2002
Pfizer/Monsanto act on drug name confusion
1 September 1999
Showing 1-5 of 5 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
